$4.020
-0.271 (-6.73%)Al cierre
- High
- 4.250
- Open
- 4.100
- VWAP
- 4.09
- Vol
- 32.87K
- Mkt Cap
- 1.98M
- Low
- 4.010
- Amount
- 134.54K
- EV/EBITDA, TTM
- 0.00
ENvue Medical, Inc., formerly NanoVibronix, Inc., is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
Métricas de valoración
Cronología de eventos
Noticias
7.501-28BenzingaENvue Medical Partners with U-Deliver for Nationwide Distribution of ENFit Syringes
5.001-21GlobenewswireENvue Medical Appoints Marc Waldman as VP of Commercial to Drive Revenue Growth
5.001-14NewsfilterENvue Medical Launches ENFit Syringes to Meet Clinical Needs
3.501-09GlobenewswireENvue Medical Launches New Program to Alleviate Discomfort from Nasogastric Tubes
1.001-08GlobenewswireENvue Medical to Ring Nasdaq Opening Bell on January 14, 2026
NAOV FAQ — answered by Alphio AI
ENvue Medical, Inc., formerly NanoVibronix, Inc., is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.